Sr Scientist
Merck
Currently, I work on analytical method development for iCIEF, LC, rDNA and CE-SDS to study antibodies and ADCs at Merck. Before joining Merck I worked as a scientist at the Formulation Development Group at Regeneron, where I contributed to the development and stability assessment of new biologics candidate anticancer antibodies. Prior to joining Regeneron, I was a postdoctoral researcher at Columbia University, where I modified yeast for diagnostic and therapeutic applications.
Disclosure information not submitted.
Comprehensive Assessment of Microchip Zone Electrophoresis to Study Large Molecule Therapeutics
Tuesday, July 14, 2026
11:00 AM - 11:30 AM East Coast USA Time